We can't find the internet
Attempting to reconnect
16639.1 PFLS-LS
Assessment of a drug candidate for the treatment of two rare orphan diseases: Morquio type B disease and GM1 gangliosidosis
Zusammenfassung
Assessment of a drug candidate for the treatment of two rare orphan diseases: Morquio type B disease and GM1 gangliosidosis
Weitere Texte
Abstract
Morquio type B disease and GM1 gangliosidosis are two rare orphan genetic disorders caused by mutated forms of the enzyme beta-galactosidase. A selective beta-galactosidase inhibitor was identified as a potential rescuer of the mutated enzyme as it helps the folding of the enzyme in vitro. The current project proposes to synthesize this potent drug with improved routing, to measure its efficacy on patient cells and to assess its in vivo bioavailability.
Beteiligte
Julie Charollais-Thoenig
Wirtschaftspartner
charollais@dorphan.com
Dorphan SA CHE-407.871.618 Julie Charollais-Thoenig Chemin de l'Eglise 7 1066 Epalinges VD CH
Roger Marti
Kontaktperson
roger.marti@hefr.ch
HEIA-FR Haute Ecole d'ingénierie et d'archi de Fribourg Roger Marti Boulevard de Pérolles 80 1700 Fribourg FR CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2014-07-31
- Enddatum
- 2015-11-30
- Bewilligte Gesamtkosten
- CHF 156225.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T115 Medical technology 100.0%